Published in Anal Chem on October 22, 2015
ImageJ for microscopy. Biotechniques (2007) 13.89
Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm (2000) 4.93
Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci (1999) 3.27
What is the true solubility advantage for amorphous pharmaceuticals? Pharm Res (2000) 2.42
Mini-beam collimator enables microcrystallography experiments on standard beamlines. J Synchrotron Radiat (2009) 2.29
Amorphous pharmaceutical solids: preparation, characterization and stabilization. Adv Drug Deliv Rev (2001) 1.77
Ritonavir: an extraordinary example of conformational polymorphism. Pharm Res (2001) 1.39
Crystallization of indomethacin from the amorphous state below and above its glass transition temperature. J Pharm Sci (1994) 1.23
The quantitative analysis of crystallinity using FT-Raman spectroscopy. Pharm Res (1998) 1.19
Characterization of the solid-state: spectroscopic techniques. Adv Drug Deliv Rev (2001) 1.17
Solid-state analysis of the active pharmaceutical ingredient in drug products. Drug Discov Today (2003) 1.10
Synchronous digitization for high dynamic range lock-in amplification in beam-scanning microscopy. Rev Sci Instrum (2014) 1.02
Integrated nonlinear optical imaging microscope for on-axis crystal detection and centering at a synchrotron beamline. J Synchrotron Radiat (2013) 1.02
Selective detection and quantitation of organic molecule crystallization by second harmonic generation microscopy. Anal Chem (2010) 1.00
Dissolution and precipitation behavior of amorphous solid dispersions. J Pharm Sci (2011) 0.98
NMR studies of organic polymorphs and solvates. Analyst (2006) 0.97
Characterization and performance of MALDI on a triple quadrupole mass spectrometer for analysis and quantification of small molecules. Anal Chem (2005) 0.97
Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture. Pharm Res (2007) 0.95
Dissolution rates of high energy polyvinylpyrrolidone (PVP)-sulfathiazole coprecipitates. J Pharm Sci (1969) 0.95
Inhibition of indomethacin crystallization in poly(vinylpyrrolidone) coprecipitates. J Pharm Sci (1995) 0.93
Nonlinear optical imaging for sensitive detection of crystals in bulk amorphous powders. J Pharm Sci (2012) 0.93
Identifying the stable polymorph early in the drug discovery-development process. Pharm Dev Technol (2005) 0.92
Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions. Pharm Res (2009) 0.91
Quantification of crystallinity in substantially amorphous materials by synchrotron X-ray powder diffractometry. Pharm Res (2005) 0.88
Single particle nonlinear optical imaging of trace crystallinity in an organic powder. Anal Chem (2011) 0.88
Crystallization and dissolution behavior of naproxen/polyethylene glycol solid dispersions. J Phys Chem B (2013) 0.83
An investigation into the crystallisation behaviour of an amorphous cryomilled pharmaceutical material above and below the glass transition temperature. J Pharm Sci (2010) 0.79
Characterisation of particle properties and compaction behaviour of hydroxypropyl methylcellulose with different degrees of methoxy/hydroxypropyl substitution. Eur J Pharm Sci (1999) 0.78
Polymorph selection: the role of nucleation, crystal growth and molecular modeling. Curr Opin Drug Discov Devel (2007) 0.77